Inhibition of Aurora A Kinase in Combination with Chemotherapy Induces Synthetic Lethality and Overcomes Chemoresistance in Myc-Overexpressing Lymphoma.
Steven I ParkCarolina P LinNatalie RenSteven P AngusDirk P DittmerMichael FooteTrevor PartonAadra P BhattYuri D FedoriwDaniel P RothMarissa L CannGary L JohnsonBlossom DamaniaPublished in: Targeted oncology (2020)
Our data demonstrate that AURKA inhibition induces synthetic lethality and overcomes chemoresistance in Myc-overexpressing lymphoma. The combination of MLN8237 and conventional chemotherapy showed promising safety and anti-tumor activities in preclinical models of Myc-positive NHL.